Subscribe for stories that matter!
The recent shareholder decision regarding the merger between Strongbridge Biopharma and Xeris Pharmaceuticals was a nearly unanimous yes. John George covered the implications of that…
John H. Johnson, CEO of Strongbridge.Image via LinkedIn.
Like a high school boy searching for a prom date, Strongbridge Biopharma talked to a number…
Before we send you to this site, please subscribe to our daily newsletter.